Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001129928-22-000002
Filing Date
2022-01-11
Accepted
2022-01-11 11:43:09
Documents
3
Period of Report
2022-01-11

Document Format Files

Seq Description Document Type Size
1 6-K form6klettertoshareholders.htm 6-K 18318
2 EX-99.1 lettertoshareholders.htm EX-99.1 34150
3 image_0.jpg GRAPHIC 933863
  Complete submission text file 0001129928-22-000002.txt   1339828
Mailing Address 804, 322 - 11 AVENUE SW CALGARY A0 T2R 0C5
Business Address 804, 322 - 11 AVENUE SW CALGARY A0 T2R 0C5 4036707380
ONCOLYTICS BIOTECH INC (Filer) CIK: 0001129928 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-38512 | Film No.: 22523186
SIC: 2834 Pharmaceutical Preparations